Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Platelet-rich plasma significantly improves outcomes in patients with tennis elbow

21.03.2013
Platelet rich plasma (PRP) therapy has been used to manage pain associated with torn tendons, muscles and ligaments, mostly in athletes, at all levels.

Though it has anecdotally been successful, the evidence to support its efficaciousness is weak. Researchers at the Rothman Institute at Jefferson participated in a multi-center randomized prospective study to evaluate the clinical value of PRP versus an active control group to determine its effectiveness in managing the pain and tenderness associated with tennis elbow.

The results will be presented on Thursday, March 21, 2013, at 5 pm, McCormick Place, Room N427 at the annual meeting of the American Academy of Orthopedic Surgeons (AAOS) in Chicago.

Tennis elbow, lateral epicondylar tendinopathy, is characterized by pain radiating from the outside of the elbow to the forearm and back of the hand when grasping or twisting. The pain associated with tennis elbow can be chronic and severe.

Researchers examined 230 patients with chronic tennis elbow. All had at least three months of symptoms and had failed conventional therapy. One hundred sixteen received treatment with PRP and 114 were in the control. All received .25 percent of the anesthetic bupivacaine with epinephrine, then the PRP group received one injection of PRP placed in the extensor tendon. Both groups were followed for up to 24 weeks. No differences were noted between the PRP and control groups prior to treatment.

PRP was prepared from venous whole blood via a desktop centrifuge and disposable canister at the point of care. The centrifuge separated the platelet-rich plasma, concentrated platelets and white blood cells, which were then injected at the site of the patient's injury. In theory, the growth factors that platelets secrete (not including human growth hormone) spur tissue recovery.

At 12 weeks, the PRP patients reported 55 percent improvement in their pain scores compared to 47 percent in the active control group. At 24 weeks, the PRP patients reported 71 percent improvement compared to 56 percent in the control group.

At 12 weeks, 37.4 percent of patients in the PRP group reported significant elbow tenderness versus 48 percent in the control group. At 24 weeks, the numbers again reflected this trend: 29 percent of PRP patients had significant tenderness versus 54 percent in the control. No significant complications occurred in either group.

The study showed the efficacy and level of results that can be obtained when using PRP as part of a treatment regimen. PRP is safe and results in improvements in pain scores and local tenderness compared to an active control group.

Thomas Jefferson University Hospitals

Thomas Jefferson University Hospitals (TJUH) are dedicated to excellence in patient care, patient safety and the quality of the healthcare experience. Consistently ranked by U.S. News & World Report among the nation's top hospitals, Thomas Jefferson University Hospital, established in 1825, has over 900 licensed acute care beds with major programs in a wide range of clinical specialties. TJUH is one of the few hospitals in the U.S. that is both a Level 1 Trauma Center and a federally-designated regional spinal cord injury center. TJUH patient care facilities include Jefferson Hospital for Neuroscience, the region's only dedicated hospital for neuroscience, Methodist Hospital in South Philadelphia, and additional patient care facilities throughout Pennsylvania and New Jersey. TJUH partners with its education affiliate, Thomas Jefferson University.

Lee-Ann Landis | EurekAlert!
Further information:
http://www.jefferson.edu

More articles from Health and Medicine:

nachricht Finnish research group discovers a new immune system regulator
23.02.2018 | University of Turku

nachricht Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Attoseconds break into atomic interior

A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.

In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...

Im Focus: Good vibrations feel the force

A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.

By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Basque researchers turn light upside down

23.02.2018 | Physics and Astronomy

Finnish research group discovers a new immune system regulator

23.02.2018 | Health and Medicine

Attoseconds break into atomic interior

23.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>